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Figure S2. Fluorescence spectra displaying the reversible condensation and decondensation of the duplex S1·S2. Figure S3 . Fluorescence spectra of the ODN S2 and the duplex S2·S5 at pH 7.
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Synthesis of A PY Scheme 1 Synthesis of pyrene-labeled deoxyadenosine derivatives.
N6-Benzoyl-5´-O-[bis(4-methoxyphenyl)phenylmethyl]-8-(1-ethynylpyrenyl)-2´-deoxyadenosine (2).
( 9, 158.0, 157.9, 152.5, 148.7, 144.2, 137.4, 135.5, 135.3,133.3, 132.5, 132.3, 130.5, 130.3, 129.6, 129.5, 129.4, 129.0, 128.4, 127.7, 127.4, 127.3, 127.1, 26.7,126.6, 126.3, 126.2, 125.9, 124.4, 124.0, 123.7, 123.4, 113.5, 112.6, 96.8, 85.9, 85.0, 82.5, 72.7, 63.6, 54.7, 36.9 
N6-Benzoyl-5´-O-[bis(4-methoxyphenyl)phenylmethyl]-8-(1-ethynylpyrenyl)-3´-{bis[1-
methylethyl)phosphoramidyl]cyanoethyl}-2´-deoxyadenosine (3)
. 4-Methylmorpholine (55 µL, 0.50 mmol) was added to a solution of 2 (150 mg, 0.16 mmol) in CH 2 Cl 2 (2 mL) under N 2 and then the mixture was stirred at room temperature for 5 min. 2-Cyanoethyldiisopropylaminochlorophosphoramidite (48 µL, 0.22 mmol) was added, after which the mixture was stirred and monitored by TLC. After 1 h, the solvent was evaporated in vacuo and the residue purified chromatographically through a short column (SiO 2 ; hexane/EtOAc/Et 3 N, 97:97:6) to yield 3 (160 mg, 87% 163.9, 157.9, 152.5, 150.4, 148.7, 144.3, 137.7, 135.5, 135.4, 133.4, 132.6, 132.4, 132.3, 130.7, 130.4, 129.9, 129.6, 129.5, 129.0, 128.4, 
Solid-phase oligonucleotide synthesis
The phosphoramidite A PY was introduced as a building block to produce fluorescent oligodeoxynucleotides (ODNs) on a controlled-pore glass (CPG) solid support, using the phosphoramidite approach and an automated DNA synthesizer (POLYGEN DNA-Synthesizer). For comparison, unmodified ODNs were also prepared. The synthesized ODNs were cleaved from the solid support upon treatment with 30% aqueous NH 4 OH (1.0 mL) for 10 h at 55 °C.
The crude products from the automated ODN synthesis were lyophilized and diluted with distilled water (1 mL). The
ODNs were purified through HPLC (Merck LichoCART C18 column; 10  250 mm; 10 µm; pore size: 100 Å). The HPLC mobile phase was held isocratically for 10 min with 5% MeCN/0.1 M triethylammonium acetate (TEAA) (pH 7.0) at a flow rate of 2.5 mL/min. The gradient was then increased linearly over 10 min, from 5 to 50% MeCN/0.1 M TEAA, at the same flow rate. The fractions containing the purified ODN were cooled and lyophilized. 80% Aqueous AcOH was added to the ODN. After 30 min at ambient temperature, the AcOH was evaporated under reduced pressure. The residue was diluted with water (1 mL); this solution was then purified through HPLC using the same 
